188 related articles for article (PubMed ID: 26900806)
1. Angiotensin-Converting Enzyme Inhibitors-Beneficial Effects Seen in Many Patient Groups May Not Extend to Kidney Transplant Recipients.
Cross NB; Webster AC
Transplantation; 2016 Mar; 100(3):472-3. PubMed ID: 26900806
[No Abstract] [Full Text] [Related]
2. [Treatment of elderly hypertension].
Rakugi H
Nihon Jinzo Gakkai Shi; 2009; 51(4):471-5. PubMed ID: 19601556
[No Abstract] [Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantation.
Morath C; Schmied B; Mehrabi A; Weitz J; Schmidt J; Werner J; Buchler MW; Morcos M; Nawroth PP; Schwenger V; Doehler B; Opelz G; Zeier M
Clin Transplant; 2009 Dec; 23 Suppl 21():33-6. PubMed ID: 19930314
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of calcium channel blocker in hypertensive patients with chronic kidney disease].
Morihira M; Kikuchi K; Nakagawa N; Fujino T; Hasebe N
Nihon Jinzo Gakkai Shi; 2009; 51(4):451-5. PubMed ID: 19601552
[No Abstract] [Full Text] [Related]
5. Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment.
Ponticelli C; Cucchiari D
J Nephrol; 2017 Apr; 30(2):155-157. PubMed ID: 28211033
[No Abstract] [Full Text] [Related]
6. [HOMED-BP].
Asayama K; Ohkubo T; Imai Y
Nihon Rinsho; 2006 Aug; 64 Suppl 6():459-64. PubMed ID: 16983777
[No Abstract] [Full Text] [Related]
7. Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease.
Linas SL
Clin J Am Soc Nephrol; 2008 Jan; 3 Suppl 1(Suppl 1):S17-23. PubMed ID: 18178792
[TBL] [Abstract][Full Text] [Related]
8. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
9. [Pathophysiology of mild hypertension: role of endothelial function].
Matsuoka H; Imaizumi T
Nihon Rinsho; 2008 Aug; 66(8):1517-24. PubMed ID: 18700551
[No Abstract] [Full Text] [Related]
10. Calcium channel blockers or angiotensin-converting enzyme inhibitors for de novo hypertension after liver transplant: and the winner is …?
Carbone M; Sagar V; Ferguson J; Neuberger J
Transplantation; 2012 Jan; 93(2):e2-4. PubMed ID: 22234315
[No Abstract] [Full Text] [Related]
11. Blood pressure control in kidney transplantation: therapeutic implications.
Premasathian NC; Muehrer R; Brazy PC; Pirsch JD; Becker BN
J Hum Hypertens; 2004 Dec; 18(12):871-7. PubMed ID: 15318162
[TBL] [Abstract][Full Text] [Related]
12. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
Luna E; Cerezo I; Macias R; Villa J; Martinez C; Cubero J; Martinez R; Ferreira F; García C
Transplant Proc; 2011; 43(6):2187-90. PubMed ID: 21839229
[TBL] [Abstract][Full Text] [Related]
13. Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.
Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
Expert Opin Investig Drugs; 2010 Sep; 19(9):1027-37. PubMed ID: 20649501
[TBL] [Abstract][Full Text] [Related]
14. Is RAS blockade routinely indicated in hypertensive kidney transplant patients?
Salzberg DJ
Curr Hypertens Rep; 2007 Nov; 9(5):422-9. PubMed ID: 18177591
[TBL] [Abstract][Full Text] [Related]
15. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
[TBL] [Abstract][Full Text] [Related]
16. [Principal entity of hypertension version of CKD guide].
Kimura G
Nihon Jinzo Gakkai Shi; 2009; 51(4):442-5. PubMed ID: 19601550
[No Abstract] [Full Text] [Related]
17. Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials.
Cross NB; Webster AC; Masson P; O'connell PJ; Craig JC
Transplantation; 2009 Jul; 88(1):7-18. PubMed ID: 19584673
[TBL] [Abstract][Full Text] [Related]
18. [Hypertension 2007-2008].
Chatzikyrkou C; Menne J; Haller H
Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
[TBL] [Abstract][Full Text] [Related]
19. Stage IV chronic kidney disease.
Hirsch S
N Engl J Med; 2010 May; 362(20):1942-3; author reply 1943. PubMed ID: 20496469
[No Abstract] [Full Text] [Related]
20. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report.
Opelz G; Zeier M; Laux G; Morath C; Döhler B
J Am Soc Nephrol; 2006 Nov; 17(11):3257-62. PubMed ID: 17035607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
